Archive · 24 Jun 2025
India Pushes for New Sickle Cell Disease Treatments
Doctors are working to find new medicines for sickle cell disease.
Currently, the main medicine is hydroxyurea, which helps many patients but not all.
Also, people need to take this medicine for their whole lives.
Because of these issues, the government is giving money to help scientists find better medicines.
This is because the disease affects the red blood cells and causes health problems.
ICMR scientist emphasizes the need for new drugs for sickle cell disease.
Hydroxyurea is the primary effective drug but is ineffective for some patients.
Patients require lifelong hydroxyurea treatment.
The government announced a 10 crore award to develop a new drug for sickle cell disease.
The Bhagwan Birsa Munda Prize was also introduced for drug development.
- Who
- ICMR scientists and the Tribal Affairs Ministry.
- What
- The urgent need to identify new drugs for sickle cell disease.
- When
- Recently, with announcements of awards and prizes for drug development.
- Where
- India.
- Why
- To improve treatment and quality of life for patients with sickle cell disease.
- Main Drug
- Hydroxyurea
- Drug Ineffectiveness
- Some patients
- Treatment Duration
- Lifelong
- Government Award
- Rs 10 crore
- Prize Instituted
- Bhagwan Birsa Munda Prize
